Peroxisome biogenesis disorders, including Zellweger syndrome (ZS), neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease, are lethal hereditary diseases caused by abnormalities in peroxisomal assembly. To date, 12 genotypes have been identified. We now have evidence that the complete human cDNA encoding Pex13p, an SH3 protein of a docking factor for the peroxisome targeting signal 1 receptor (Pex5p), rescues peroxisomal matrix protein import and its assembly in fibroblasts from PBD patients of complementation group H. In addition, we detected mutations on the human PEX13 cDNA in two patients of group H. A severe phenotype of a ZS patient (H-02) was homozygous for a nonsense mutation, W234ter, which results in the loss of not only the SH3 domain but also the putative transmembrane domain of Pex13p. A more mildly affected NALD patient (H-01), whose fibroblasts showed the temperature-sensitive (TS) phenotype, was homozygous for a missense mutation in the SH3 domain of Pex13p, I326T. This mutant PEX13 cDNA expression in a PEX13-defective CHO mutant showed I326T to be a TS mutation and thus suggested that Pex13p with the I326T mutation in the SH3 domain is stable at 30°°°°C but is somewhat unstable at 37°°°°C.
INTRODUCTION
Peroxisomal disorders represent an expanding group of genetic disorders in humans and comprise~20 different disorders. Generally, the peroxisomal disorders are divided into two groups, with peroxisome biogenesis disorders (PBD) and single peroxisomal enzyme deficiencies. The PBDs include Zellweger syndrome (ZS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease and rhizomelic chondrodysplasia punctata (RCDP) type 1. Our recent studies have shown that there is genetic heterogeneity among these patients, as concluded from complementation studies which have so far shown 13 different groups (1). This has been made possible by the successful use of selective yeast and Chinese hamster ovary (CHO) cell mutants. The underlying genes of eight complementation groups to date identified include: PEX1 [PBD group E, group 1 at the Kennedy Krieger Institute (KKI)] (2-4), PEX2 (group F, 10 at KKI) (5), PEX5 (group 2 at KKI) (6, 7) , PEX6 (group C, 4 at KKI) (8, 9) , PEX7 (RCDP; group R, 11 at KKI) (10) (11) (12) , PEX10 (group B, 7 at KKI) (13, 14) , PEX12 (group 3 at KKI) (15, 16) and PEX16 (group D, 9 at KKI) (17) .
The exact functional role of these different PEX gene products (peroxines) is largely unknown, with the exception of Pex5p, the peroxisome targeting signal (PTS) 1 receptor, and Pex7p, the PTS2 receptor, although almost all of these peroxines are involved in the uptake of peroxisomal matrix proteins (18) .
A central role in peroxisomal assembly is played by PEX13 protein (Pex13p) together with Pex14p (19, 20) . Pex13p is a peroxisomal membrane protein containing an SH3 domain exposed to the cytosolic space and which probably functions as a docking site for Pex5p loaded with its cargo, a peroxisomal matrix protein containing a PTS1 signal (21) (22) (23) . The corresponding PEX13 gene was identified in yeast and in humans (21) (22) (23) ) and a complete cDNA encoding human Pex13p, 39 amino acids longer than previously reported, was cloned (20) . Pex13p may play a role in peroxisomal protein import in humans; however, we did not find a PBD complementation group that affected Pex13p, using an expression vector constructed with the 39 amino acid shorter human PEX13 (24) . We now report that the gene defective in complementation group H (24) 
RESULTS

Studies in fibroblasts from group H patients
Two patients have so far been identified as belonging to the new complementation group H. The first one (H-01) showed a relatively mild phenotype (NALD), as described elsewhere in detail (24) , whereas the second patient (H-02) had true ZS. Dihydroxyacetone phosphate acyltransferase (DHAP-AT) activity was strongly deficient in fibroblasts from patient H-02 but normal in fibroblasts from patient H-01 ( Table 1 ). The activity of the peroxisomal β-oxidation system as measured by oxidation of lignocelic acid relative to that of palmitic acid was also severely decreased in H-02 fibroblasts and only mildly decreased in the H-01 cells (Table 1) . Immunofluorescence studies revealed no punctate immunofluorescence with anticatalase and anti-PTS1 antibodies in H-02 fibroblasts ( Fig. 1f  and g ), in contrast to numerous particles in control fibroblasts ( Fig. 1a and b) . A somewhat different picture was found in H-01 fibroblasts. Indeed, although no punctate immunofluorescence was found with anti-catalase (Fig. 2a) , significant particle-bound immunofluorescence was observed with the anti-PTS1 antibody (Fig. 2b) . In the study of peroxisomal ghost membrane protein, using anti-human 70 kDa peroxisomal integral membrane protein (PMP70) antibody, larger and fewer PMP70-containing particles were seen in H-02 fibroblasts and fewer particles in H-01 fibroblasts, as compared with findings in control fibroblasts (Figs 1c and h, and 2c; Table 1 ). Furthermore, after 7 days of incubation at 30°C, a definite punctate staining pattern was detected in fibroblasts from patient H-01 (Fig. 2d) but not from patient H-02, suggesting that H-01 fibroblasts had a temperaturesensitive (TS) peroxisome assembly phenotype (25, 26) .
Expression of hsPEX13: restoration of PTS-1 import and peroxisomal assembly in fibroblasts from ZS and NALD patients of group H We transfected fibroblasts representing 12 different PBD complementation groups, except for RCDP, with an expression vector containing the complete human PEX13 cDNA (pUcD2PEX13). Numerous punctate structures were seen in fibroblasts from a ZS patient of group H (H-02), using immunofluorescent staining with anti-human catalase and anti-PTS1 antibodies ( Fig. 1i and j), whereas no particle-bound immunofluorescence was found when stained with anti-catalase and anti-PTS1 antibodies before transfection ( Fig. 1f and g ). To confirm that these structures were indeed peroxisomes, we experimented with double immunofluorescence staining using guinea pig anti-rat catalase antibody and rabbit anti-human PMP70 antibody. In the control fibroblasts, the localizations of catalase ( Fig. 1d ) and PMP70 ( Fig. 1e) were similar, whereas only PMP70-containing particles were detected in H-02 fibroblasts (data not shown). In the H-02 transfectants with pUcD2PEX13, punctate structures stained with both anti-catalase and anti-PMP70 were detected and localization of both patterns was similar ( Fig. 1k and l) . This means that hsPEX13 rescues PTS1 import and peroxisome assembly.
In fibroblasts from the other patient belonging to group H (H-01), which had no catalase-containing particles prior to transfection (Fig. 2a) , punctate fluorescence was extensive after transfection with pUcD2PEX13, determined using an anti-human catalase antibody (Fig. 2e) , whereas many particles were stained even before transfection using an anti-PTS1 antibody (Fig. 2b) . In fibroblasts from the other 11 complementation groups PTS1 import and peroxisome assembly were not rescued (data not shown). These findings suggest that hsPEX13 is the pathogenic gene of group H.
Mutation analysis and TS mutation of hsPEX13 in group H
To determine the dysfunction of PEX13 in patients of H-01 and H-02, the coding region of the complete cDNA for hsPEX13 was amplified by RT-PCR. Direct sequencing of cDNA from patient H-02 indicated a single point mutation (G→A) at position 702 in codon 234 (Trp), resulting in creation of termination codon, TGA (designated W234ter) (Fig. 3a) . As this W234ter mutation abolished the BalI site in hsPEX13 cDNA, the 460 bp PCR products (373-832) obtained from a control and H-01 and H-02 cDNA were digested with BalI. The PCR products obtained from H-02 cDNA were not sensitive to BalI, whereas the control and H-01 cDNAs were completely digested with BalI, thereby indicating absence of the 702 G→A mutation (Fig. 4) . To determine the zygosity of the W234ter mutant allele, genomic DNA fragments corresponding to nucleotide residues 563-752 in the PEX13 cDNA were amplified by PCR. There was no intron present in this region. Only a single type of nucleotide sequence giving rise to the W234ter mutation was identified in the PCR products (data not shown). These results suggest that the H-02 patient was homozygous for the W234ter mutation. When pUcD2PEX13/ W234ter was transfected back into H-02 fibroblasts, no particle was stained with anti-catalase, and anti-PTS1 antibodies were evident ( Fig. 1m and n) , which implies that the W234ter mutation probably has a dramatic effect on the function of Pex13p.
In the mild phenotype of PBD (NALD patient H-01), direct sequencing of cDNA from H-01 fibroblasts indicated only a point mutation (T→C) at position 977 in codon 326 (Ile), resulting in a change to a Thr codon (designated I326T) (Fig. 3b) . Genomic DNA fragments corresponding to nucleotide residues 924-1042 in the PEX13 cDNA obtained by PCR were also found to contain only a single type of nucleotide sequence giving rise to the I326T mutation, suggesting that patient H-01 was homozygous for this missense mutation. When pUcD2PEX13/I326T was transfected into H-02 fibroblasts (ZS phenotype), no particle stained with an anti-catalase antibody (Fig. 2f) , but many particles did stain with an anti-PTS1 antibody, as seen in the transfectants (Fig. 2g) . No PTS1-containing particles were seen in H-02 fibroblasts transfected with pUcD2PEX13/W234ter (Fig. 1n) . Thus, the I326T mutation mildly affected hsPEX13 function, leading to leakage in PTS1 import but a failure of peroxisome assembly.
After 7 days incubation at 30°C, punctate staining of catalase was detected in H-01 fibroblasts (Fig. 2d) , indicating that these fibroblasts carry the TS phenotype. Therefore, to assess the TS phenomenon of the I326T mutation in hsPEX13, stable transfectants of pUcD2PEX13/W234ter and pUcD2PEX13/I326T into the PEX13-defective CHO mutant ZP128 (R. Toyama et al., unpublished data) (not TS phenotype) were incubated at 30°C. Numerous catalase-positive granules appeared in the transfectants of pUcD2PEX13/I326T into ZP128 after 7 days of incubation at 30°C (Fig. 2i) , whereas granules were rarely seen at 37°C (Fig. 2h) . On the other hand, there were no catalase-positive granules in stable transfectants of pUcD2PEX13/ W234ter into ZP128 at both 37 and 30°C (Fig. 2j and k) . Therefore, it seems clear that the missense mutation I326T in hsPEX13 was indeed the TS mutation.
DISCUSSION
In the light of previously published reports, yeast Pex13p is an SH3 protein of the peroxisome membrane and a PTS1 receptor docking factor with a major role in peroxisome assembly. To date, no mammalian mutant defective in PEX13 has been published, whereas a human homolog has been published for yeast Pex13p (20, 23) . Thus, it was unknown whether Pex13p is functional in humans. Our data demonstrate that Pex13p is
Figure 1. Complementation of peroxisomes in fibroblasts from a ZS patient (H-02). (a-e) Fibroblasts from control; (f-h) fibroblasts from patient H-02; (i-l) H-02
fibroblasts transfected with pUcD2PEX13; (m and n) H-02 fibroblasts transfected with pUcD2PEX13/W234ter. Cells were stained using antibodies to human catalase (a, f, i and m), PTS1 (b, g, j and n) or human PMP70 (c and h). A double immunofluorescence staining method was used as well as guinea pig anti-rat catalase and rhodamine-conjugated goat anti-guinea pig antibodies (d and k) and rabbit anti-human PMP70 and FITC-conjugated goat anti-rabbit antibodies (e and l). Bar = 10 µm. Expression of hsPEX13 rescues PTS1 import and peroxisome assembly in H-02 fibroblasts (i-k), but not expression of hsPEX13/W234ter (m and n).
at Pennsylvania State University on February 23, 2013 http://hmg.oxfordjournals.org/ Downloaded from indeed essential for PTS1 import and peroxisome assembly in humans and that Pex13p-related dysfunction can cause disorders. We also transfected the mutant cells with an expression vector containing the 39 amino acid shorter human PEX13 cDNA (23) . With careful observation after long-term culture, catalase-positive particles were seen in the transfectants (data not shown); therefore, the 39 amino acid shorter Pex13p may have some function in peroxisome assembly. Abolition of PEX13 activity, determined by deletion of the SH3 domain of yeast Pex13p (Y286ter, corresponding to Y281ter in human Pex13p) suggested that the SH3 domain is essential for its function (23) . The W234ter mutation of hsPEX13 in patient H-02 (severe phenotype) leads to a truncated protein lacking not only the SH3 domain but also the putative transmembrane domain of human Pex13p (23) . This mutation may affect Pex13p function, as based on findings in expression experiments, and hence patient H-02, with this mutation, has the severe phenotype of ZS.
On the other hand, the NALD patient H-01 had a missense mutation in the SH3 domain of human Pex13p (I326T) and Pex13p function is only mildly affected. This may explain why H-01 fibroblasts show failure only of catalase import, residual β-oxidation activity and normal DHAP-AT activity and the patient had only a mild clinical phenotype (NALD). Human catalase has a poorer variant of PTS1 and may therefore be more susceptible to the effects of mutations in the import machinery (27) . As I326T is a TS mutation, the SH3 domain with the I326T mutation in Pex13p is stable at 30°C but is somewhat unstable at 37°C, presumably due to a change(s) in the three-dimensional structure of this mutated Pex13p. There is a report that HsPex14p interacts with Pex5p and Pex13p (20) , so further characterization of the interactions of these proteins is necessary to better understand peroxisomal protein import and biogenesis. Pex13p is a good model for analyzing mechanisms of peroxisome assembly and protein import in humans.
MATERIALS AND METHODS
Morphological analysis
Peroxisomes in fibroblasts were visualized by indirect immunofluorescence light microscopy as described (5), using rabbit antibodies to human and rat catalase, PTS1 (28) and human PMP70 (29) . For double immunofluorescence staining, guinea pig antirat catalase and rabbit anti-human PMP70 antibodies and rhodamine-conjugated goat anti-guinea pig and FITCconjugated goat anti-rabbit secondary antibodies were used, using a method reported elsewhere (30) .
Isolation and transfection of complete human PEX13 cDNA
We searched for peroxisome-restoring cDNA clones by genetic functional complementation of peroxisome deficiency of a newly identified CHO cell mutant clone, ZP128 (R. Toyama et al., unpublished data). A transient transfection assay was done using a human liver cDNA library constructed in vector pCMVSPORTI (Gibco BRL, Rockville, MD) as described (4, 16) . The isolated cDNA clone, termed hsPEX13, was inserted into the pUcD2SRαMCSHyg vector (16) . The resulting plasmid, named pUcD2PEX13, was transfected into fibroblasts from 12 complementation groups of PBD patients by the calcium phosphate method (5) and selected with hygromycin B for 10 days.
Mutation analysis of hsPEX13 in group H
hsPEX13 cDNA (GenBank accession no. AF048755) was synthe- To assess the effect of mutations in H-01 and H-02 patients, pUcD2PEX13/W234ter and pUcD2PEX13/I326T were constructed using QuikChange Site-Directed Mutagenesis kits (Stratagene, La Jolla, CA) from normal complete hsPEX13 cDNA, transfected into H-02 fibroblasts by the calcium phosphate transfection method (5) and selected with hygromycin B. The immunofluorescence study was performed 10 days later using anti-human catalase and anti-PTS1 antibodies. To assess the TS phenomenon of the I326T mutation in hsPEX13, stable transfectants of pUcD2PEX13/I326T were obtained by transfection into the PEX13-defective CHO mutant ZP128 (phenotype not TS; data not shown) using a Gene Pulser II electroporator (Bio-Rad, Hercules, CA) at 300 V and 400 µF and selection in the presence of hygromycin and were incubated at 30°C for 7 days followed by immunocytochemical observation. 
Other methods
Assignment of both patients to complementation group H was done by complementation analysis using catalase immunofluorescence as the marker (31) . The activities of the peroxisomal β-oxidation system and DHAP-AT were determined as described (32, 33) . 
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